Alaunos Therapeutics Ownership | Who Owns Alaunos Therapeutics?


OverviewForecastRevenueFinancialsChart

Alaunos Therapeutics Ownership Summary


Alaunos Therapeutics is owned by 1.69% institutional investors, 14.11% insiders, and 84.20% retail investors. Vanguard group is the largest institutional shareholder, holding 1.38% of TCRT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.56% of its assets in Alaunos Therapeutics shares.

TCRT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAlaunos Therapeutics1.69%14.11%84.20%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group30.06K1.38%$97.10K
Geode capital management22.56K1.16%$64.53K
Blackrock funding, inc. /de21.35K1.10%$61.07K
Vanguard fiduciary trust15.50K0.80%$44.32K
Hrt financial lp13.33K0.68%$38.00K
Two sigma investments, lp10.84K0.56%$31.00K
Citadel advisors10.52K0.54%$30.08K
Xtx topco10.17K0.52%$29.10K
Ubs group2.27K0.12%$6.50K
Advisor group1.78K0.09%$5.08K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Xtx topco10.17K0.00%$29.10K
Tower research capital llc (trc)1.58K0.00%$4.53K
Hrt financial lp13.33K0.00%$38.00K
Cwm8.00-$23.00
Federation des caisses desjardins du quebec70.00-$200.00
Eversource wealth advisors---
Thurston, springer, miller, herd & titak---
Steward partners investment advisory92.00-$263.00
Advisor group1.78K-$5.08K
Barclays---

Top Buyers

HolderShares% AssetsChange
Vanguard fiduciary trust15.50K-15.50K
Citadel advisors10.52K-10.52K
Xtx topco10.17K0.00%10.17K
Vanguard group30.06K-9.09K
Geode capital management22.56K-2.82K

Top Sellers

HolderShares% AssetsChange
Two sigma investments, lp10.84K--7.75K
Morgan stanley653.00--994.00
Group one trading---300.00
Raymond james financial---99.00
Citigroup1.00--88.00

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust15.50K-15.50K$44.32K
Citadel advisors10.52K-10.52K$30.08K
Xtx topco10.17K0.00%10.17K$29.10K
Vanguard global advisers501.00-501.00$1.43K
Royal bank of canada185.00-185.00$1.00K

Sold Out

HolderChange
Truvestments capital-1.00
Wealthspire advisors-1.00
Jpmorgan chase-3.00
Psi advisors-6.00
Investment management corp /va/ /adv-6.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202616-38.46%32,877-69.71%16.83%5-37.50%2-66.67%
Dec 31, 20258-66.67%31,589-51.57%19.56%2-71.43%2-60.00%
Sep 30, 20255-80.77%21,173-70.16%16.43%1-83.33%--100.00%
Jun 30, 20256-76.92%21,065-70.09%16.80%1-83.33%--100.00%
Mar 31, 202526-10.34%70,434-2.20%421.75%6-25.00%5-58.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF24.91K1.56%-15.49K
Vanguard Total Stock Mkt Idx Inv17.35K1.08%-7.03K
Fidelity Extended Market Index15.28K0.64%2.81K
Vanguard Institutional Extnd Mkt Idx Tr14.06K0.59%-
BlackRock Extended Equity Market K2.98K0.19%-2.00
Extended Equity Market Fund E3.42K0.15%-
Extended Equity Market Fund B3.42K0.15%-
Blackrock Extended Mkt Fund CF3.42K0.14%-
Extended Equity Market Fund K2.92K0.13%-21.00
BlackRock Extended Equity Market Fund K2.92K0.12%-21.00

Recent Insider Transactions


DateNameRoleActivityValue
Jun 24, 2025Vieser Jaime-Buy$1.12K
Jun 24, 2025Postma Robert W-Buy$2.69K
Apr 11, 2025Postma Robert W-Buy$1.38K
Dec 31, 2024Vieser Jaime-Sell$4.39K
Dec 31, 2024Vieser Jaime-Sell$1.64K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1--
2025 Q4--
2025 Q3--
2025 Q23-

TCRT Ownership FAQ


Who Owns Alaunos Therapeutics?

Alaunos Therapeutics shareholders are primarily institutional investors at 1.69%, followed by 14.11% insiders and 84.20% retail investors. The average institutional ownership in Alaunos Therapeutics's industry, Biotech Stocks , is 35.75%, which Alaunos Therapeutics falls below.

Who owns the most shares of Alaunos Therapeutics?

Alaunos Therapeutics’s largest shareholders are Vanguard group (30.06K shares, 1.38%), Geode capital management (22.56K shares, 1.16%), and Blackrock funding, inc. /de (21.35K shares, 1.10%). Together, they hold 3.63% of Alaunos Therapeutics’s total shares outstanding.

Does Blackrock own Alaunos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Alaunos Therapeutics.

Who is Alaunos Therapeutics’s biggest shareholder by percentage of total assets invested?

Xtx topco is Alaunos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 10.17K Alaunos Therapeutics shares, valued at 29.1K$.

Who is the top mutual fund holder of Alaunos Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Alaunos Therapeutics shares, with 1.56% of its total shares outstanding invested in 24.91K Alaunos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools